Stocktoria
Inspire Medical Systems, Inc. INSP
NYSE · XNYS · stock · Surgical & Medical Instruments & Apparatus · website · IPO 2018-05-03
Inspire Medical Systems, Inc. financials (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $912.0M | $802.8M | $624.8M | $407.9M | $233.4M |
| Gross profit | $778.8M | $679.8M | $528.2M | $341.7M | $200.1M |
| R&D expense | $103.2M | $114.1M | $116.5M | $68.6M | $37.4M |
| SG&A expense | $624.6M | $529.6M | $452.0M | $320.7M | $202.6M |
| Operating income | $51.0M | $36.1M | -$40.3M | -$47.6M | -$39.9M |
| Interest expense | — | — | $0 | $1.7M | $2.1M |
| Income tax | -$79.7M | $4.9M | $1.2M | $613,000 | $72,000 |
| Net income | $145.4M | $53.5M | -$21.2M | -$44.9M | -$42.0M |
| EPS (diluted) | $4.89 | $1.75 | $-0.72 | $-1.60 | $-1.54 |
| Operating cash flow | $117.0M | $130.2M | $24.7M | $11.6M | -$20.1M |
| Free cash flow | $78.5M | $91.1M | $1.0M | $2.5M | -$24.8M |
| Cash & equivalents | $104.8M | $150.2M | $185.5M | $441.6M | $214.5M |
| Inventory | $145.3M | $80.1M | $33.9M | $11.9M | $17.2M |
| Total assets | $907.3M | $808.4M | $676.8M | $564.9M | $295.1M |
| Total liabilities | $126.2M | $118.7M | $104.3M | $68.9M | $66.0M |
| Shareholders' equity | $781.2M | $689.7M | $572.5M | $496.0M | $229.0M |
Source: SEC EDGAR filings · CIK 0001609550 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.